SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Drolet, B.
Right arrow Articles by Turgeon, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drolet, B.
Right arrow Articles by Turgeon, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pimozide (Orap®) Prolongs Cardiac Repolarization by Blocking the Rapid Component of the Delayed Rectifier Potassium Current in Native Cardiac Myocytes

Benoit Drolet, MSc

Institut de cardiologie de Quebec, Hôpital Laval et Facultés de, Universiti Laval, Sainte-Foy, Quebec, Canada; Institut de cardiologie de Quebec, Pharmnacie et de, Universiti Laval, Sainte-Foy, Quebec, Canada; Centre de Recherche, Hôpital du Sacré-Cawur de Montréal, Departement de Pharmacologie, Faculte de, Montréal, Quebec, Canada

Guy Rousseau, PhD

Centre de Recherche, Hôpital du Sacré-Cawur de Montréal, Departement de Pharmacologie, Faculte de, Montréal, Quebec, Canada; Centre de Recherche, Medecine et Faculte de, Montréal, Quebec, Canada

Pascal Daleau, PhD

Centre de Recherche, Hôpital du Sacré-Cawur de Montréal, Departement de Pharmacologie, Faculte de, Montréal, Quebec, Canada;; Institut de cardiologie de Quebec, Médecine, Universiti Laval, Sainte-Foy, Quebec, Canada

René Cardinal, PhD

Centre de Recherche, Hôpital du Sacré-Cawur de Montréal, Departement de Pharmacologie, Faculte de, Montréal, Quebec, Canada; Centre de Recherche, Medecine et Faculte de, Montréal, Quebec, Canada

Chantale Simard, MSc

Centre de Recherche, Pharmacie, Université de Montréal, Montréal, Quebec, Canada

Jacques Turgeon, PhD

Institut de cardiologie de Quebec, Hôpital Laval et Facultés de, Universiti Laval, Sainte-Foy, Quebec, Canada; Centre de Recherche, Hôpital du Sacré-Cawur de Montréal, Departement de Pharmacologie, Faculte de, Montréal, Quebec, Canada; Centre de Recherche, Pharmacie, Université de Montréal, Montréal, Quebec, Canada

Background: Several cases of QT prolongation and ventricular tachyarrhythmia have been reported with pimozide, a potent neuroleptic useful in the management of motor and phonic tics associated with Tourette syndrome. To further elucidate the mechanism underlying these clinical observations, the effects of pimozide on monophasic action potential duration (MAPD9O) and on potassium currents involved in the repolarization of native isolated ventricular myocytes were examined.

Methods and Results: Studies were undertaken in eight isolated guinea pig hearts that demonstrated reverse rate-dependent prolongation of cardiac repolarization by pimozide 100 nmol/L. Action potential duration increased 24% from baseline 115 ± 2 to 142 ± 4 msec with pimozide 100 nmol/L during pacing at 250 msec cycle length, while a 10% increase from 97 ± 2 to 107 ± 3 msec was seen with pacing at a cycle length of 150 msec. Experiments in native isolated ventricular myocytes (n = 20) demonstrated concentration-dependent block of the rapid component (I,) of the delayed rectifier potassium current: tail current was decreased by 50% at 15 nmol/L.

Conclusions: Pimozide possesses cardiac electrophysiological effects similar to those of class III antiarrhythmic drugs. These effects are concentration-dependent and observed at recommended dosages of the drug. Since pimozide is strongly metabolized by CYP3A4, special care should be taken to avoid potential pharmacokinetic interactions leading to high plasma levels of pimozide and proarrhythmia.

Key Words: pimozide • potassium currents • repolarization • cardiac arrhythmia

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 6, No. 3, 255-260 (2001)
DOI: 10.1177/107424840100600306


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
R. W. Freudenmann and P. Lepping
Delusional Infestation
Clin. Microbiol. Rev., October 1, 2009; 22(4): 690 - 732.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
P. Morissette, R. Hreiche, L. Mallet, D. Vo, E. E. Knaus, and J. Turgeon
Olanzapine prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current
J Psychopharmacol, September 1, 2007; 21(7): 735 - 741.
[Abstract] [PDF]



Advertisement